• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1989 Fiscal Year Final Research Report Summary

Study on binding specificity of anti-gangliosides monoclonal antibodies

Research Project

Project/Area Number 62580141
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field 物質生物化学
Research InstitutionTokyo Metropolitan Institute of Medical Science

Principal Investigator

TAI Tadashi  Tokyo Metropolitan Institute of Medical Science, Department of Tumor Immunology, Head, 腫瘍免疫, 研究員 (70112092)

Co-Investigator(Kenkyū-buntansha) TADA Nobuhiko  Tokai University School of Medicine, Associate Professor, 医学部, 助教授 (80167494)
KAWASHIMA Ikuo  Tokyo Metropolitan Institute of Medical Science, Department of Tumor Immunology,, 腫瘍免疫, 研究員 (40146824)
Project Period (FY) 1987 – 1989
KeywordsGangliosides / Monoclonal antibody / Tumor antigen / Melanoma / Neuroblastoma
Research Abstract

The fine structural specificities of six monoclonal antibodies (MAbs) to ganglioside GD2 were studied. These MAbs were produced by hybridomas obtained from A/J mice immunized with EL4 (C57BL/6 derived-T lymphoma). The binding specificities of these MAbs were found to differ from each other by virtue of their binding to structurally related authentic standard glycosphingolipids as revealed by three different assay systems. The MAbs examined could be divided into three binding types. Three MAbs A1-201, A1- 410, and Al-425 bound specifically to ganglioside GD2 and none of the other gangliosides tested. Two other MAbs Al-245 and Al-267 reacted not only with GD2, but also several other gangliosides. In addition, these MAbs were found to distinguish between different N-acetyl- and N-glycolyl- neuraminic acid derivatives of ganglioside GD3. The last MAb A1-287 reacted with several other gangliosides but with lower avidity than A1-245 and A1-267. These six MAbs, furthermore, reacted with ganglioside GD2 lactones. The reactivities of these antibodies to various ganglioside lactones also differ from each other.

  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] T.Tai: "Monoclonal antibody detects monosialogangliosides having a sialic acidα2→3galactosyl residue." J.Biol.Chem.262. 6803-6807 (1987)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Tai: "Different reactivities of monoclonal antibodies to ganglioside lactones." Biochem.Biophys.Acta. 958. 134-138 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] I.Kawashima: "Mouse monoclonal antibodies detecting-disialogangliosides on mouse and human T-lymphomas." Int.J.Cancer. 41. 267-274 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Tai: "Monoclonal antibody R24 distinguishes between different N-acetyl and N-glycolyl neuraminic acid derivatives of ganglioside GD3." Arch.Biochem.Biophys.260. 51-55 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Tai: "Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2." J.Biochem.(Tokyo). 103. 313-318 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Hamanaka: "Strong anti-tumor effect of monosialogangliosides specific monoclonal antibody 202." J.Dermatology. 16. 480-486 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Tai: "UCLA Symposium on Molecular and Cellular Biology" Alan R.Liss,New York, 83-92 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Tai: "Gangliosides and Cancer" VCH Publishers,Weinheim, 149-158 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T. Tai: "Monoclonal antibody detects monosialogangliosides having a sialic acid 2-3galactosyl residue" J. Biol. Chem., 262, 6803-6807, 1987.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T. Tai: "Different reactivities of monoclonal antibodies to ganglioside lactones" Biochim. Biophys. Acta, 958, 134-138, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] I. Kawashima: "Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T-lymphomas" Int. J. Cancer, 41, 267-274, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T. Tai: "Monoclonal antibody R24 distinguishes between different N-acetyl and N-glycolyl neuraminic acid derivatives of ganglioside GD3" Arch. Biochem. Biophys., 260, 51-55, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T. Tai: "Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2" J. Biochem. (Tokyo), 103, 313-318, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T. Tai: "Different fine binding specificities of monoclonal antibodies to ganglioside GD2" UCLA Symposium on Molecular and Cellular Biology, 99, 83-92, 1989.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T. Tai: "Mouse monoclonal antibodies to ganglioside GD2: characterization of the fine structural specificities, Gangliosides and Cancer (H.Oettgen ed.)" VCH Publishers, Weinheim, pp. 149-158, 1989.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Hamanaka: "Strong anti-tumor effect of monoclonal antibody 202 specific for monosialogangliosides" J. Dermatology.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Nakamura: "Serotherapy of murine T cell leukemia with monoclonal antibodies specific for ganglioside GD2" Cancer Res.

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi